Optimerede antistoffer rettet mod CD19
The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an Fcg³R or alters effector function as compared to the parent antibody. Also disclosed are methods of us...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Danish |
Published |
04.07.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an Fcg³R or alters effector function as compared to the parent antibody. Also disclosed are methods of using said antibodies. |
---|---|
AbstractList | The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein the modification alters affinity to an Fcg³R or alters effector function as compared to the parent antibody. Also disclosed are methods of using said antibodies. |
Author | Pong, Erik WeiKing Richards, John O Desjarlais, John R KARKI, Sher Bahadur Lazar, Gregory Alan Zhukovsky, Eugene Alexander Bernett, Matthew J Chu, Seung Yup |
Author_xml | – fullname: Bernett, Matthew J – fullname: Richards, John O – fullname: Zhukovsky, Eugene Alexander – fullname: KARKI, Sher Bahadur – fullname: Lazar, Gregory Alan – fullname: Pong, Erik WeiKing – fullname: Desjarlais, John R – fullname: Chu, Seung Yup |
BookMark | eNrjYmDJy89L5WRQ8y8oycxNLUpNSVVIzCvJLC7JT0tLLVIoSi0pSS1RyM1PUXB2MbTkYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxLt5GxhbGRpbmISGmxsSoAQA6kCk_ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | DK2383297TT5 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_DK2383297TT53 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:01:02 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Danish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_DK2383297TT53 |
Notes | Application Number: DK20110173336T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220704&DB=EPODOC&CC=DK&NR=2383297T5 |
ParticipantIDs | epo_espacenet_DK2383297TT5 |
PublicationCentury | 2000 |
PublicationDate | 20220704 |
PublicationDateYYYYMMDD | 2022-07-04 |
PublicationDate_xml | – month: 07 year: 2022 text: 20220704 day: 04 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | Xencor, Inc |
RelatedCompanies_xml | – name: Xencor, Inc |
Score | 3.414012 |
Snippet | The present disclosure describes antibodies that target CD19, wherein the antibodies comprise at least one modification relative to a parent antibody, wherein... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
Title | Optimerede antistoffer rettet mod CD19 |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220704&DB=EPODOC&locale=&CC=DK&NR=2383297T5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwrSt-KaNuv6UIQlLcOxdUiVvY1kSWEPc2Wr-O97Ka36om8hgUvy4y6XS-4D4IHovgjzwHUI2leO7ynpSNfLHRXoXCBTa7o00ciTaX_06j_P6bwFqyYWpsoT-lklR0SJWqK8l9V5Xfw8YvHKt3L3KFfYtXlKsojbtXVMCHKwb_NhFM9SnjKbsYiP7elLhJrJI2GQ0T3YN7dok2Y_fhuaoJTit0ZJTuBghsTey1NoKdGBI9YUXuvA4aT-78ZmLXq7M7DTwtSB32qlLUTDZAQwpU0s42irS2u9URbjbngO90mcsZGDEy6-N7fg42ZpGfUuoI1Gv74ES0sl9GBJPATSFz0lA0WFq92eCAdSUHIF3b_pdP8bvIZjA1TlcurfQLvcfuhbVKylvKsg-QJiq314 |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH_MKc6bTkXnVwXprbim7boeirBmZdp1G1Jlt5E0KeygG1vFf9-X0KoXvYUE8vHjvTx-yfsAuCOyx4LCty2C_MpyHcEtbjuFJXxZMBRq6eUqGjmd9EYv7tPcmzdgWcfC6Dyhnzo5ImpUjvpe6vt6_fOIRbVv5faeL7Fr9RBnITUrdkwISrBr0kE4nE3pNDKjKKSJOXkO0TI5JPAzbwd2fWSEmim9DlRQyvq3RYkPYW-Gk72XR9AQrA2tqC681ob9tPrvxmalettjMKdrVQd-I4U0EA2VEUCVNjGUo60sjbeVMCJqBydwGw-zaGThgovvwy1oUm8t85xTaCLpl2dgSC6Y7OfEQSBd1hXcFx6zpd1lQZ8zj5xD5-95Ov8N3kBrlKXjxfhxklzAgQJNu5-6l9AsNx_yCo1sya81PF9ldYBi |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Optimerede+antistoffer+rettet+mod+CD19&rft.inventor=Bernett%2C+Matthew+J&rft.inventor=Richards%2C+John+O&rft.inventor=Zhukovsky%2C+Eugene+Alexander&rft.inventor=KARKI%2C+Sher+Bahadur&rft.inventor=Lazar%2C+Gregory+Alan&rft.inventor=Pong%2C+Erik+WeiKing&rft.inventor=Desjarlais%2C+John+R&rft.inventor=Chu%2C+Seung+Yup&rft.date=2022-07-04&rft.externalDBID=T5&rft.externalDocID=DK2383297TT5 |